Insiders Imugene Limited

Equities

Market Closed - Australian S.E. Other stock markets 07:10:14 09/05/2024 BST			5-day change	1st Jan Change
0.07 ^AUD	-6.67%		-16.67%	-36.36%

04-16	Imugene Signs Deal to Sell Manufacturing Facility For $6 Million	MT
04-16	Kincell Bio, LLC signed an asset purchase agreement to acquire North Carolina manufacturing facility from Imugene Limited for $6 million.	CI

Imugene Appoints Medical Chief	04/09/23	MT
Imugene Limited Appoints Paul Woodard as Chief Medical Officer	04/09/23	CI
Imugene Limited Appoints John Byon as Senior Vice President of Clinical Development	01/09/23	CI
Imugene Limited Appoints Dr Bradley Glover as Chief Operating Officer	21/08/23	CI
Imugene Appoints Dr Weitzman Interim Chief Medical Officer	18/07/23	CI
Australian shares rise on mining, tech boost; new RBA governor appointed	14/07/23	RE
Imugene Limited Announces Board Changes	20/06/23	CI
Imugene Announces Company Secretary Changes	02/03/23	CI
Imugene Names Chief Medical Officer; Shares Rise 3%	04/10/22	MT
Imugene Limited Appoints Giovanni Selvaggi as Chief Medical Officer	03/10/22	CI
Imugene Appoints Jakob Dupont as Non- Executive Director	07/09/22	CI
Imugene Appoints CFO	18/07/22	MT
Imugene Limited Appoints Mike Tonroe as Chief Financial Officer, Effective from September 2022	18/07/22	CI
Imugene Limited Announces Appointment of Dr. Sharon Yavrom as Executive Director, Clinical Scientist	01/07/22	CI
Imugene Limited Announces Board Changes	01/06/22	CI
Imugene Names Medical Chief; Shares Up 4%	01/02/22	MT
Imugene Limited Announces Appointment of Steven Cha as Chief Medical Officer and Member of the Executive Management Team	31/01/22	CI
Imugene's Chief Medical Officer to Retire; Shares Fall 4%	21/01/22	MT
Imugene Limited Announces Retirement of Rita Laeufle as Chief Medical Officer and the Board	20/01/22	CI
Imugene Limited Announces Management Changes	03/01/22	CI

No results for this search